Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy-Reference-Cited by-同舟云学术

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy

Published:2020-11-09 Issue:3 Volume:185 Page:629-638
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Liu Shiwei,Zeng Shiyan,Xia Li,Yu Miao,Zhang Xin,Yang Hong,Ji Juan,Dong Hao,Zhang Jianhui,Zhang Purong^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-020-06015-4.pdf

Reference46 articles.

1. DeSantis CE, Ma J, Goding Sauer A et al (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67:439–448. https://doi.org/10.3322/caac.21412

2. Slamon DJ, Clark GM, Wong SG et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182. https://doi.org/10.1126/science.3798106

3. Dawood S, Hu R, Homes MD et al (2011) Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat 126:185–192. https://doi.org/10.1007/s10549-010-1113-7

4. Takada M, Ishiguro H, Nagai S et al (2014) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study). Breast Cancer Res Treat 145:143–153. https://doi.org/10.1007/s10549-014-2907-9

5. Cortazar P, Zhang L, Untch M et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384:164–172. https://doi.org/10.1016/S0140-6736(13)62422-8

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour budding, MELF-pattern and tumour-infiltrating lymphocytes as possible pathomorphological parameters of the course of endometrioid adenocarcinoma of the uterine corpus;Tumors of female reproductive system;2024-07-29

2. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients;The Breast;2023-04

3. Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis;BJS Open;2022-05-02

4. DDTNet: A dense dual-task network for tumor-infiltrating lymphocyte detection and segmentation in histopathological images of breast cancer;Medical Image Analysis;2022-05